Advocate-BREAST80+: A Comprehensive Patient and Advocate-Led Study to Enhance Breast Cancer Care Delivery and Patient-Centered Research in Women Aged ≥80 Years.

Ciara C O'SullivanRobert A VierkantNicole L LarsonMary Lou SmithCynthia ChauhanFergus J CouchJanet E OlsonStacy D'AndreAminah JatoiKathryn J Ruddy

Published in: Cancers (2024)

Although P80+ experienced less anxiety and symptom-related distress compared with P80-, they were significantly less satisfied with information regarding the side effects of BC therapies and their management. P80+ were significantly less likely to have participated in a clinical trial or be open to considering this option. Future studies should address educational needs pertaining to side effects and barriers to research participation in P80+.

Keyphrases

clinical trial
polycystic ovary syndrome
physical activity
minimally invasive
case report
current status
study protocol
pregnant women
sleep quality
adipose tissue
metabolic syndrome
case control
cervical cancer screening
drug induced